Literature DB >> 7813516

Heterogeneity of peroxisomes in human hepatoblastoma cell line HepG2. Evidence of distinct subpopulations.

M Schrader1, E Baumgart, A Völkl, H D Fahimi.   

Abstract

Peroxisomes in human hepatoblastoma cell line HepG2 have been studied using immunocytochemical, ultrastructural and biochemical techniques. By immunofluorescence, small spherical peroxisomes were seen next to rod-shaped and elongated forms. By electron microscopy and catalase cytochemistry, small particles with a diameter of 90 to 100 nm were found next to larger ones measuring up to 300 nm and some exhibiting tail-like extensions. Both the intensity of DAB-staining and the immunolabeling density for catalase were heterogenous in different peroxisomes. Contrary to a recent biochemical study, the enzyme alanine-glyoxylate-aminotransferase was found by double immunofluorescence and immunoelectron microscopy to be localized exclusively in peroxisomes of HepG2 cells. By Metrizamide density gradient centrifugation two populations of peroxisomes were isolated: a regular fraction banding at 1.20 g/cm3 with a mean diameter of 222 nm and a lighter peroxisome fraction banding at 1.14 g/cm3. The ratio of lipid beta-oxidation enzymes to catalase was significantly higher in peroxisomes with lower density than in the regular ones. These observations show clearly the existence of heterogenous populations of peroxisomes in HepG2 cells which may provide a useful model system for the investigation of biogenesis and metabolism of peroxisomes of human origin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813516

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  15 in total

Review 1.  A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.

Authors:  Ayumu Sugiura; Gian-Luca McLelland; Edward A Fon; Heidi M McBride
Journal:  EMBO J       Date:  2014-08-08       Impact factor: 11.598

2.  Fluorescent tools to analyse peroxisome-ER interactions in mammalian cells.

Authors:  Alexa Bishop; Maki Kamoshita; Josiah B Passmore; Christian Hacker; Tina A Schrader; Hans R Waterham; Joseph L Costello; Michael Schrader
Journal:  Contact (Thousand Oaks)       Date:  2019-05-15

3.  Effects of fixation on the preservation of peroxisomal structures for immunofluorescence studies using HepG2 cells as a model system.

Authors:  M Schrader; E Baumgart; H D Fahimi
Journal:  Histochem J       Date:  1995-08

Review 4.  In situ heterogeneity of peroxisomal oxidase activities: an update.

Authors:  R J Van den Munckhof
Journal:  Histochem J       Date:  1996-06

5.  Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).

Authors:  E Baumgart; I Vanhorebeek; M Grabenbauer; M Borgers; P E Declercq; H D Fahimi; M Baes
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Mammalian NADH diphosphatases of the Nudix family: cloning and characterization of the human peroxisomal NUDT12 protein.

Authors:  Salama R Abdelraheim; David G Spiller; Alexander G McLennan
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

7.  The hypolipidemic compound cetaben induces changes in Golgi morphology and vesicle movement.

Authors:  Werner J Kovacs; Michael Schrader; Ingrid Walter; Herbert Stangl
Journal:  Histochem Cell Biol       Date:  2004-07-28       Impact factor: 4.304

Review 8.  Mammalian peroxisomes and reactive oxygen species.

Authors:  Michael Schrader; H Dariush Fahimi
Journal:  Histochem Cell Biol       Date:  2004-07-08       Impact factor: 4.304

9.  FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid oxidation enzymes in peroxisomes.

Authors:  F S Wouters; P I Bastiaens; K W Wirtz; T M Jovin
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

10.  Self-interaction of human Pex11pβ during peroxisomal growth and division.

Authors:  Nina A Bonekamp; Sandra Grille; Maria Joao Cardoso; Monica Almeida; Miguel Aroso; Silvia Gomes; Ana Cristina Magalhaes; Daniela Ribeiro; Markus Islinger; Michael Schrader
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.